|
Re: Dr. Kausik Ray on BETonMACE
|
7
|
Resverlogix Corp.
|
Dec 08, 2019 08:48AM
|
|
Re: Report Of Exempt Distribution.
|
7
|
Zenith Epigenetics
|
Apr 16, 2024 07:13PM
|
|
Re: Kausik Ray tweeted this this morning
|
7
|
Resverlogix Corp.
|
Aug 18, 2022 04:07PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
7
|
Zenith Epigenetics
|
Sep 19, 2017 09:30AM
|
|
Re: My one-minute commercial for Apabetalone
|
7
|
Resverlogix Corp.
|
Sep 10, 2019 09:12PM
|
|
Re: Rules of thumb and broken thumbs...
|
7
|
Resverlogix Corp.
|
Sep 29, 2020 09:09AM
|
|
Time for a package deal??
|
7
|
Zenith Epigenetics
|
Jan 10, 2022 09:43AM
|
|
Re: RVX News (Events) are being picked up in USA
|
7
|
Resverlogix Corp.
|
Oct 05, 2016 09:03AM
|
|
Re: Thought Provoking
|
7
|
Resverlogix Corp.
|
Mar 14, 2018 10:20AM
|
|
Re: Impact of news
|
7
|
Resverlogix Corp.
|
Feb 05, 2020 07:55PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
7
|
Resverlogix Corp.
|
Sep 05, 2017 10:37AM
|
|
Re: New PP on Aug 13
|
7
|
Zenith Epigenetics
|
Aug 20, 2019 10:22AM
|
|
Re: This is Great
|
7
|
Resverlogix Corp.
|
Nov 08, 2023 09:18AM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
7
|
Resverlogix Corp.
|
Jun 22, 2022 04:31PM
|
|
Re: And we wait.......
|
7
|
Resverlogix Corp.
|
Jan 24, 2018 07:58AM
|
|
Re: Momentum Players and Agoracom.com’s Rules
|
7
|
Resverlogix Corp.
|
Dec 21, 2021 11:52AM
|
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
7
|
Resverlogix Corp.
|
Jan 18, 2022 08:18AM
|
|
Epigenetics market size
|
7
|
Zenith Epigenetics
|
Jan 16, 2024 12:18PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
7
|
Resverlogix Corp.
|
Dec 15, 2021 07:25PM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
7
|
Zenith Epigenetics
|
Sep 27, 2024 11:55AM
|
